Meletios Dimopoulos, MD, Kapodistrian University of Athens School of Medicine, Athens, Greece, discusses TOURMALINE-MM4 (NCT02312258), a Phase III trial of oral ixazomib maintenance therapy in participants with newly diagnosed multiple myeloma not treated with stem cell transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).